chr1-181790116-C-T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_001205293.3(CACNA1E):​c.5787-329C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.209 in 151,964 control chromosomes in the GnomAD database, including 3,368 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.21 ( 3368 hom., cov: 32)

Consequence

CACNA1E
NM_001205293.3 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -1.15

Publications

1 publications found
Variant links:
Genes affected
CACNA1E (HGNC:1392): (calcium voltage-gated channel subunit alpha1 E) Voltage-dependent calcium channels are multisubunit complexes consisting of alpha-1, alpha-2, beta, and delta subunits in a 1:1:1:1 ratio. These channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. This gene encodes the alpha-1E subunit of the R-type calcium channels, which belong to the 'high-voltage activated' group that maybe involved in the modulation of firing patterns of neurons important for information processing. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011]
CACNA1E Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 69
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neurodevelopmental disorder
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 1-181790116-C-T is Benign according to our data. Variant chr1-181790116-C-T is described in ClinVar as Benign. ClinVar VariationId is 1239719.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.289 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001205293.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1E
NM_001205293.3
MANE Select
c.5787-329C>T
intron
N/ANP_001192222.1
CACNA1E
NM_000721.4
c.5787-329C>T
intron
N/ANP_000712.2
CACNA1E
NM_001205294.2
c.5730-329C>T
intron
N/ANP_001192223.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1E
ENST00000367573.7
TSL:1 MANE Select
c.5787-329C>T
intron
N/AENSP00000356545.2
CACNA1E
ENST00000360108.7
TSL:5
c.5730-329C>T
intron
N/AENSP00000353222.3
CACNA1E
ENST00000367570.6
TSL:1
c.5787-329C>T
intron
N/AENSP00000356542.1

Frequencies

GnomAD3 genomes
AF:
0.209
AC:
31701
AN:
151846
Hom.:
3365
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.232
Gnomad AMI
AF:
0.337
Gnomad AMR
AF:
0.182
Gnomad ASJ
AF:
0.173
Gnomad EAS
AF:
0.250
Gnomad SAS
AF:
0.303
Gnomad FIN
AF:
0.202
Gnomad MID
AF:
0.269
Gnomad NFE
AF:
0.191
Gnomad OTH
AF:
0.225
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.209
AC:
31706
AN:
151964
Hom.:
3368
Cov.:
32
AF XY:
0.211
AC XY:
15701
AN XY:
74238
show subpopulations
African (AFR)
AF:
0.232
AC:
9593
AN:
41420
American (AMR)
AF:
0.181
AC:
2772
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.173
AC:
602
AN:
3472
East Asian (EAS)
AF:
0.250
AC:
1285
AN:
5146
South Asian (SAS)
AF:
0.302
AC:
1458
AN:
4822
European-Finnish (FIN)
AF:
0.202
AC:
2126
AN:
10538
Middle Eastern (MID)
AF:
0.248
AC:
73
AN:
294
European-Non Finnish (NFE)
AF:
0.191
AC:
13018
AN:
67982
Other (OTH)
AF:
0.225
AC:
473
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1303
2607
3910
5214
6517
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
350
700
1050
1400
1750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.197
Hom.:
472
Bravo
AF:
0.207
Asia WGS
AF:
0.254
AC:
883
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.070
DANN
Benign
0.49
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs601059; hg19: chr1-181759252; API